EDGAR Filing Documents for 0001615774-15-003551

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001615774-15-003551

Filing Date

2015-12-02

Accepted

2015-12-02 14:34:13

Documents

Period of Report

2015-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	s102183_10q.htm	10-Q	513633
2	EXHIBIT 10.1	s102183_ex10-1.htm	EX-10.1	27605
3	EXHIBIT 31.1	s102183_ex31-1.htm	EX-31.1	9851
4	EXHIBIT 31.2	s102183_ex31-2.htm	EX-31.2	9784
5	EXHIBIT 32.1	s102183_ex32-1.htm	EX-32.1	5279
6	EXHIBIT 32.2	s102183_ex32-2.htm	EX-32.2	5334
7	GRAPHIC	img001_v1.jpg	GRAPHIC	5537
8	GRAPHIC	tex99-1pg1.jpg	GRAPHIC	8987
	Complete submission text file	0001615774-15-003551.txt		3642842

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE FILE	cttc-20150630.xml	EX-101.INS	517390
10	XBRL SCHEMA FILE	cttc-20150630.xsd	EX-101.SCH	50283
11	XBRL CALCULATION FILE	cttc-20150630_cal.xml	EX-101.CAL	53842
12	XBRL DEFINITION FILE	cttc-20150630_def.xml	EX-101.DEF	202203
13	XBRL LABEL FILE	cttc-20150630_lab.xml	EX-101.LAB	353189
14	XBRL PRESENTATION FILE	cttc-20150630_pre.xml	EX-101.PRE	257919

Mailing Address 1375 KINGS HIGHWAY EAST FAIRFIELD CT 06824

Business Address 1375 KINGS HIGHWAY EAST FAIRFIELD CT 06824 (203) 368-6044

CALMARE THERAPEUTICS Inc (Filer) CIK: 0000102198 (see all company filings)